- Home
- LTRN vs LUCD Comparison
LTRN vs LUCD Comparison
Compare LTRN & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- LUCD
- Stock Information
- Founded
- LTRN 2013
- LUCD 2018
- Country
- LTRN United States
- LUCD United States
- Employees
- LTRN N/A
- LUCD N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LTRN Health Care
- LUCD Health Care
- Exchange
- LTRN Nasdaq
- LUCD Nasdaq
- Market Cap
- LTRN 35.4M
- LUCD 38.4M
- IPO Year
- LTRN 2020
- LUCD 2021
- Fundamental
- Price
- LTRN $3.11
- LUCD $0.79
- Analyst Decision
- LTRN Hold
- LUCD Strong Buy
- Analyst Count
- LTRN 1
- LUCD 4
- Target Price
- LTRN N/A
- LUCD $3.63
- AVG Volume (30 Days)
- LTRN 77.7K
- LUCD 613.4K
- Earning Date
- LTRN 11-07-2024
- LUCD 11-13-2024
- Dividend Yield
- LTRN N/A
- LUCD N/A
- EPS Growth
- LTRN N/A
- LUCD N/A
- EPS
- LTRN N/A
- LUCD N/A
- Revenue
- LTRN N/A
- LUCD $4,189,000.00
- Revenue This Year
- LTRN N/A
- LUCD $91.80
- Revenue Next Year
- LTRN N/A
- LUCD $139.27
- P/E Ratio
- LTRN N/A
- LUCD N/A
- Revenue Growth
- LTRN N/A
- LUCD 179.27
- 52 Week Low
- LTRN $2.79
- LUCD $0.63
- 52 Week High
- LTRN $11.99
- LUCD $1.58
- Technical
- Relative Strength Index (RSI)
- LTRN 41.22
- LUCD 34.85
- Support Level
- LTRN $3.28
- LUCD $0.76
- Resistance Level
- LTRN $3.60
- LUCD $0.83
- Average True Range (ATR)
- LTRN 0.43
- LUCD 0.06
- MACD
- LTRN -0.06
- LUCD -0.01
- Stochastic Oscillator
- LTRN 0.00
- LUCD 13.19
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.